v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Operating activities      
Net loss $ (705,809) $ (214,118) $ (289,811)
Adjustments to reconcile net loss to net cash used in operating activities      
Change in fair value of warrant liability 42,400 (8,000) 4,700
Gain on warrant termination (39,100) 0 0
Reversal of warrant contract asset amortization (16,301) 0 0
Gain on warrant exercise (173) 0 0
Stock-based compensation 534,138 0 0
Amortization of warrant contract asset 4,843 5,221 4,720
Change in fair value of warrant asset (18,302) (4,100) 0
Gain on marketable equity securities (12,110) (9,807) 0
Loss from equity-method investments 4,228 301 595
Amortization of original issue discount 1,382 1,117 238
Amortization of deferred financing fees 510 510 139
Change in fair value of contingent consideration 72 (400) (3,701)
Depreciation and amortization 37,245 33,049 30,029
Provision for bad debt expense 680 1,646 3,867
Provision for obsolete inventory 0 0 1,938
Amortization of finance right-of-use lease assets 0 283 381
Non-cash operating lease costs 6,047 6,760 6,427
Minimum accretion expense 197 90 455
Impairment of intangible assets 0 7,359 0
PIK interest added to principal 8,811 3,587 0
Change in assets and liabilities      
Accounts receivable (61,037) (7,347) (8,203)
Inventory (9,541) (6,563) (1,312)
Prepaid expenses and other current assets (13,683) (6,474) (1,094)
Investments and other assets (751) (4,209) (2,296)
Accounts payable (23,852) (23,363) (7,915)
Deferred revenue (20,942) (26,412) 67,626
Deferred other income 39,887 0 0
Accrued data licensing fees (5,000) (9,121) (6,746)
Accrued expenses & other 50,540 38,577 22,803
Interest payable 15,129 15,836 16,395
Operating lease liabilities (8,553) (8,761) (7,439)
Net cash used in operating activities (189,045) (214,339) (168,204)
Investing activities      
Purchases of property and equipment (22,121) (34,608) (18,377)
Proceeds from sale of marketable equity securities 23,098 0 0
Purchases of marketable equity securities (36,183) 0 0
Business combinations, net of cash acquired 0 (5,705) (39,562)
Investment in joint venture (95,186) 0 0
Net cash used in investing activities (130,392) (40,313) (57,939)
Financing activities      
Proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions 381,951 0 0
Tax withholding related to net share settlement of restricted stock units (69,918) 0 0
Issuance of Series G-5 Preferred Stock 199,750 0 0
Principal payments on finance lease liabilities 0 (288) (375)
Purchase of treasury stock 0 (3,602) 0
Payment of deferred offering costs (8,766) (698) (2,883)
Payment of deferred financing fees 0 0 (2,550)
Dividends paid (5,625) (5,625) (5,625)
Proceeds from long-term debt, net of original issue discount 0 82,875 170,625
Payment of indemnity holdback related to acquisition (813) 0 0
G-4 Special Payment (2,250) 0 0
Net cash provided by financing activities 494,329 117,547 251,391
Effect of foreign exchange rates on cash 336 (19) 17
Net increase (decrease) in Cash, Cash Equivalents and Restricted Cash 175,228 (137,124) 25,265
Cash, cash equivalents and restricted cash, beginning of period 166,607 303,731 278,466
Cash, cash equivalents and restricted cash, end of period 341,835 166,607 303,731
Cash, Cash Equivalents and Restricted Cash are Comprised of:      
Cash and cash equivalents 340,954 165,767 302,938
Restricted cash 881 840 793
Total cash, cash equivalents and restricted cash 341,835 166,607 303,731
Supplemental disclosure of cash flow information      
Cash paid during the year for interest 28,045 16,913 4,664
Cash paid for income taxes 206 161 6
Marketable equity securities received on accounts receivable 22,000 22,000 0
Supplemental disclosure of noncash investing and financing activities      
Dividends Payable 5,487 12,535 5,625
Purchases of property and equipment, accrued but not paid 4,292 6,137 2,408
Deferred offering costs, accrued but not yet paid 0 3,504 2,391
Redemption of convertible promissory note 24,932 27,970 17,142
Non-voting common stock issued in connection with business combinations 344 9,209 4,947
Non-voting common stock issued in connection with contingent consideration 0 0 4,304
Accretion of convertible preferred stock to redemption value 0 4,338 301
Operating lease liabilities arising from obtaining right-of-use assets 1,997 1,097 41,815
Finance lease liabilities arising from obtaining right-of-use-assets 0 0 664
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering 1,348,809 0 0
Taxes related to net share settlement of restricted stock units not yet paid 20 0 0
Reclassification of deferred offering costs to additional paid-in capital upon initial public offering 12,347 0 0
Issuance of warrant 0 4,223 0
Issuance of common stock in connection with contingent consideration 847 0 0
Series G-3 Redeemable Convertible Preferred Stock [Member]      
Financing activities      
Issuance of Series G-4 Preferred Stock, net of offering costs 0 0 92,199
Supplemental disclosure of noncash investing and financing activities      
Issuance of Series 3,809 2,738 0
Series G-4 Redeemable Convertible Preferred Stock [Member]      
Financing activities      
Issuance of Series G-4 Preferred Stock, net of offering costs 0 44,885 0
Supplemental disclosure of noncash investing and financing activities      
Issuance of Series $ 611 $ 0 $ 0